Jeffry R. Keyes's most recent trade in Quantum-Si Incorporated - Ordinary Shares - Class A was a trade of 4,117 Class A Common Stock done at an average price of $0.9 . Disclosure was reported to the exchange on June 22, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| QuantumSi Incorporated | Jeffry R. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.90 per share. | 22 Jun 2026 | 4,117 | 1,724,349 | - | 0.9 | 3,701 | Class A Common Stock |
| QuantumSi Incorporated | Jeffry R. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.96 per share. | 22 Jun 2026 | 4,116 | 1,728,466 | - | 1.0 | 3,941 | Class A Common Stock |
| QuantumSi Incorporated | Jeffry R. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.01 per share. | 20 Apr 2026 | 37,382 | 1,769,963 | - | 1.0 | 37,621 | Class A Common Stock |
| QuantumSi Incorporated | Jeffry R. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.99 per share. | 20 Apr 2026 | 37,381 | 1,732,582 | - | 1.0 | 37,194 | Class A Common Stock |
| QuantumSi Incorporated | Jeffry R. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.83 per share. | 20 Mar 2026 | 4,422 | 1,807,345 | - | 0.8 | 3,655 | Class A Common Stock |
| QuantumSi Incorporated | Jeffry R. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.85 per share. | 20 Mar 2026 | 4,233 | 1,811,767 | - | 0.8 | 3,591 | Class A Common Stock |
| QuantumSi Incorporated | Jeffry R. Keyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2026 | 780,847 | 780,847 | - | - | Stock Option (Right to Buy) | |
| QuantumSi Incorporated | Jeffry R. Keyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2026 | 652,803 | 1,816,000 | - | 0 | Class A Common Stock | |
| QuantumSi Incorporated | Jeffry R. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.28 per share. | 22 Dec 2025 | 8,627 | 1,163,197 | - | 1.3 | 11,008 | Class A Common Stock |
| Cns Pharma Inc | Jeffry R. Keyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2025 | 1,517 | 1,517 | - | - | Option to purchase common stock | |
| QuantumSi Incorporated | Jeffry R. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.63 per share. | 22 Sep 2025 | 3,873 | 1,171,824 | - | 1.6 | 6,332 | Class A Common Stock |
| QuantumSi Incorporated | Jeffry R. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.68 per share. | 22 Sep 2025 | 3,873 | 1,175,697 | - | 1.7 | 6,517 | Class A Common Stock |
| QuantumSi Incorporated | Jeffry R. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.61 per share. | 23 Jun 2025 | 8,624 | 1,179,570 | - | 1.6 | 13,918 | Class A Common Stock |
| QuantumSi Incorporated | Jeffry R. Keyes | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.39 per share. | 21 Mar 2025 | 8,626 | 1,188,194 | - | 1.4 | 11,951 | Class A Common Stock |
| QuantumSi Incorporated | Jeffry R. Keyes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2025 | 750,000 | 1,196,820 | - | 0 | Class A Common Stock | |
| Cns Pharma Inc | Jeffry R. Keyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2024 | 17,500 | 62,928 | - | - | Option to purchase common stock | |
| Cns Pharma Inc | Jeffry R. Keyes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Apr 2024 | 17,500 | 80,428 | - | - | Restricted Stock Units | |
| Cns Pharma Inc | Jeffry R. Keyes | Director | Grant, award, or other acquisition of securities at price $ 0.30 per share. | 07 Mar 2022 | 11,100 | 11,100 (0%) | 0% | 0.3 | 3,294 | Common Stock |